Danish Partners Embark on $6.8M Personalized Cancer Diagnostics Project | GenomeWeb

NEW YORK (GenomeWeb News) – Partners in Denmark have joined to embark on a €5.2 million ($6.8 million) personalized cancer diagnostic project.

The project aims to develop a platform for precision medicine using gene expression analysis so that individual cancer patients can receive treatments that have been tailored specifically for them.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.